Less than 7% of insured Americans have ever used TrumpRx. The platform, once touted as a supermarket for affordable medications, now functions as a boutique pharmacy for a narrow segment of the uninsured.
President Trump’s prescription discount site, TrumpRx.gov, expanded to over 800 discounted medications on Friday, adding 160 new drugs from Pfizer and Gilead. The move, announced by President Trump, was intended to broaden appeal. It has not.
New data from recent surveys shows that only 7% of Americans have visited the site. Most returning users are uninsured or underinsured. Insured patients find the platform irrelevant because discounts cannot stack with insurance plans.
TrumpRx is a cash-only discount card. It is not an insurance plan. For the 92% of Americans with private or public coverage, it offers zero benefit.
“TrumpRx was never designed to be a supermarket for everyone,” said a healthcare analyst. “It is a boutique for those who fall through the cracks.”
The platform’s core design flaw remains unchanged. Uninsured users struggle with limited drug availability and complex eligibility rules. Even with over 800 medications, integration with major pharmacy chains is lacking, and patient assistance programs are restricted.
Critics argue expansion alone does not solve the fundamental problem. The platform was ‘never meant’ for insured Americans. Compared to alternatives like GoodRx, which offers broader pharmacy acceptance and insurance stacking, TrumpRx is more restrictive.
The promise of a supermarket for cheaper drugs has faded. TrumpRx delivered a boutique pharmacy with limited reach, serving only a specific audience.
| Metric | TrumpRx | GoodRx |
|---|---|---|
| Insurance stacking | No | Yes |
| Pharmacy acceptance | Limited | Broad |
| Target audience | Uninsured | All consumers |
| User adoption (insured) | 7% | Higher |
Before relying on TrumpRx, consumers should compare with other discount platforms and check if their insurance offers better value. The site’s expansion to 800+ drugs cannot mask its fundamental limitation: it serves a boutique audience of the uninsured, not the mass market of insured patients who dominate US healthcare.
💡 Frequently Asked Questions (FAQ)
- Q: What is TrumpRx and how does it work?
- A: TrumpRx is a cash-only prescription discount card, not an insurance plan. It offers discounts on medications but cannot be stacked with insurance, making it irrelevant for the 92% of Americans with coverage.
- Q: Why do only 7% of Americans use TrumpRx?
- A: Most Americans have insurance, and TrumpRx discounts cannot be combined with insurance plans. The platform is mainly used by the uninsured or underinsured, but limited drug availability and complex eligibility rules further reduce its appeal.
- Q: Does TrumpRx’s expansion to 800 drugs fix its problems?
- A: No. Critics argue expansion alone doesn’t solve fundamental issues like lack of integration with major pharmacy chains and restrictive patient assistance programs, keeping it a niche option for a narrow segment.
Extended Reading
For further context, NPR reported on July 16, 2026, that TrumpRx’s expansion included drugs from Pfizer and Gilead. The platform remains a niche option. Data from IBTimes UK noted the site was “never meant” for insured Americans, reinforcing its boutique status.